Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Onyx HealthcareROCO:6569 -0.61%76 5-Year Yield-on-Cost % is 3.17 as of Aug. 09, 2026, which is 17% below its 10-year median of 3.81. GuruFocus rates ROCO:6569 with a GF Score™ of 76/100 and a GF Value™ of NT$129.16 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 275 Healthcare Providers & Services companies, Onyx Healthcare ranks better than 54.55% on this metric.
Onyx Healthcare's yield on cost for the quarter that ended in Mar. 2026 was 3.17.
The historical rank and industry rank for Onyx Healthcare's 5-Year Yield-on-Cost % or its related term are showing as below:
ROCO:6569'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.81 Med: 3.81 Max: 11.48
Current: 3.17
During the past 13 years, Onyx Healthcare's highest Yield on Cost was 11.48. The lowest was 1.81. And the median was 3.81.
ROCO:6569's 5-Year Yield-on-Cost % is ranked better than 54.55% of 275
companies
in the Healthcare Providers & Services industry
Industry Median: 2.9
vs ROCO:6569: 3.17
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Onyx Healthcare 5-Year Yield-on-Cost % Related Terms
ROCO:6569 vs VEEV, BTSG, HQY: 5-Year Yield-on-Cost % Comparison
For the Health Information Services subindustry, Onyx Healthcare's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Onyx Healthcare 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Onyx Healthcare's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Onyx Healthcare's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Onyx Healthcare is calculated as
Onyx Healthcare (ROCO:6569) has a 5-Year Yield-on-Cost % of 3.17 as of Aug. 09, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Onyx Healthcare and its competitors. This is 17% below median its historical median of 3.81. Over the past decade, Onyx Healthcare's 5-Year Yield-on-Cost % has ranged from 1.81 to 11.48. According to the industry distribution chart, Onyx Healthcare ranks #125 out of 275 companies in the Healthcare Providers & Services industry, placing it in the top 45.5%.
Is Onyx Healthcare's 5-Year Yield-on-Cost % too high?
Onyx Healthcare's current 5-Year Yield-on-Cost % of 3.17 is 17% below median its 10-year median of 3.81. Over the past 10 years, this metric has ranged from a low of 1.81 to a high of 11.48. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.90. Onyx Healthcare's value of 3.17 is 9.3% above this industry median. Based on the distribution chart, Onyx Healthcare ranks #125 out of 275 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Onyx Healthcare has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Onyx Healthcare's 5-Year Yield-on-Cost % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Onyx Healthcare ranks #125 out of 275 companies for 5-Year Yield-on-Cost %. This puts Onyx Healthcare in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.90. Onyx Healthcare's value of 3.17 is 9.3% above this benchmark. Historically, Onyx Healthcare's own 5-Year Yield-on-Cost % has ranged from 1.81 to 11.48 over the past decade. While the company's 10-year median is 3.81 vs. the industry median of 2.90, Onyx Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.90, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onyx Healthcare's current 5-Year Yield-on-Cost % of 3.17 is 9.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Onyx Healthcare and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onyx Healthcare's current 5-Year Yield-on-Cost % is 3.17, which is 17% below median its own 10-year median of 3.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Onyx Healthcare (ROCO:6569) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$129.16, compared to a current price of NT$97.80 — trading 24.3% below its estimated fair value. The current 5-Year Yield-on-Cost % is 3.17, which is 17% below median its 10-year median of 3.81 and 9.3% above the Healthcare Providers & Services industry median of 2.90. Onyx Healthcare's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Onyx Healthcare (ROCO:6569), the current 5-Year Yield-on-Cost % is 3.17 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Onyx Healthcare (ROCO:6569) Overvalued in 2026?
Based on GuruFocus' analysis, Onyx Healthcare stock appears to be undervalued.
The current stock price of NT$97.80 is trading 24.3% below its estimated GF Value™ of NT$129.16.
GuruFocus considers Onyx Healthcare to be Modestly Undervalued.
Key valuation signals for ROCO:6569:
5-Year Yield-on-Cost %: 3.17 (17% below median its 10-year median of 3.81)
GF Value™: NT$129.16 vs. price of NT$97.80 (24.3% below fair value)
Industry Position: 9.3% above the Healthcare Providers & Services median (#125 of 275)
No single metric tells the full story. See the ROCO:6569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan, the United States, Europe, and Other countries and generates maximum revenue from Taiwan.
76GF Score
Get the complete analysis for ROCO:6569
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6569 has been successfully added to your 
